Literature DB >> 9579742

Role of nitric oxide in the development and partial reversal of allergen-induced airway hyperreactivity in conscious, unrestrained guinea-pigs.

M Schuiling1, A B Zuidhof, M A Bonouvrie, N Venema, J Zaagsma, H Meurs.   

Abstract

1. Using a conscious, unrestrained guinea-pig model of allergic asthma, we investigated the role of endogenous nitric oxide (NO) in the regulation of airway (hyper)reactivity to histamine before and after the allergen-induced early and late asthmatic reactions, by examining the effect of inhalation of the NO synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME, 12 mM, 15 min) on the histamine-induced airway obstruction of ovalbumin-sensitized guinea-pigs before, and at 5.5 h and 23.5 h after allergen challenge. 2. Before allergen challenge, inhaled L-NAME caused a significant 2.02+/-0.25 fold increase (P<0.01) in airway reactivity to histamine; this effect was reversed within 2.5 to 6 h after administration. 3. After the allergen-induced early asthmatic reaction at 5 h after ovalbumin provocation, a significant 3.73+/-0.67 fold increase (P<0.01) of the airway reactivity to histamine was observed; subsequent inhalation of L-NAME at 5.5 h had no effect on the airway hyperreactivity, reassessed at 6 h. 4. After the late asthmatic reaction, at 23 h after ovalbumin provocation, a reduced, but still significant airway hyperreactivity to histamine (2.18+/-0.40 fold; P<0.05) was observed. Subsequent inhalation of L-NAME now significantly potentiated the partially reduced airway hyperreactivity 1.57+/-0.19 fold (P<0.05) to the level observed after the early asthmatic reaction. 5. When administered 30 min before allergen exposure, L-NAME significantly enhanced the allergen-induced early asthmatic reaction. However, when administered at 5.5 h after allergen provocation, L-NAME did not affect the subsequent late asthmatic reaction. 6. These results indicate that endogenous NO is involved the regulation of histamine- and allergen-induced bronchoconstriction and that a deficiency of cNOS-derived NO contributes to the allergen-induced airway hyperreactivity to histamine after the early asthmatic reaction, while a recovery of NO deficiency may account for the partial reversal of the allergen-induced airway hyperreactivity after the late asthmatic reaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579742      PMCID: PMC1565295          DOI: 10.1038/sj.bjp.0701738

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

Review 1.  Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation.

Authors:  J W Coleman
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

2.  Airway reactivity, inflammatory cell influx and nitric oxide in guinea-pig airways after lipopolysaccharide inhalation.

Authors:  T J Toward; K J Broadley
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.

Authors:  P J Turner; J R Maggs; J C Foreman
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Deficiency of nitric oxide in polycation-induced airway hyperreactivity.

Authors:  H Meurs; F E Schuurman; M Duyvendak; J Zaagsma
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity.

Authors:  H Meurs; M A Hamer; S Pethe; S Vadon-Le Goff; J L Boucher; J Zaagsma
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs.

Authors:  J Boer; M Duyvendak; F E Schuurman; F M Pouw; J Zaagsma; H Meurs
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

7.  Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs.

Authors:  J de Boer; H Meurs; L Flendrig; M Koopal; J Zaagsma
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 8.  Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives.

Authors:  Harm Maarsingh; Johan Zaagsma; Herman Meurs
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

9.  Interleukin-12-independent down-modulation of cockroach antigen-induced asthma in mice by intranasal exposure to bacterial lipopolysaccharide.

Authors:  Steven K Lundy; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 10.  Multiple roles of nitric oxide in the airways.

Authors:  F L M Ricciardolo
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.